glp 1 parkinson's disease and neuroprotection Incretin insulin signaling as novel therapeutic targets for Alzheimer's and Neuroprotective effects of GLP-1 receptor
Description
These medications are effective at managing blood sugar levels and supporting weight loss, making them beneficial for certain health conditions
Market Players: The rise of new models like virtual-first care and organizations like Hims/Hers offering access to weight management programsincluding compounded or prescription GLP-1sfurther drives awareness and accessibility, increasing demand for employer coverage
Satiety and Nausea: Both activate satiety centers in the hypothalamus, which may contribute to the nausea commonly seen during drug initiation or dose escalation
A.deSantosS
